#US generics

Lupin Q1 Profit Rises 16% as US Sales Surge; Stock Retreats from Day's High

Mumbai-based drugmaker Lupin beat estimates with a 16.1% rise in net profit to ₹1,415 crore, driven by a 30% jump in US ...